Ultrasound-guided sepsis care for patients with cirrhosis
Part of Digestive system, Infections clinical trials.
This study tests whether using a special ultrasound of the heart can guide treatment for sepsis-related low blood pressure in patients with cirrhosis. It aims to improve care and outcomes for critically ill patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are critically ill with cirrhosis and have sepsis causing low blood pressure
- You are between 18 and 65 years old
- You are not already on medications to raise blood pressure
- You do not have serious heart or lung disease, active bleeding, or certain other conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the use of a simple ultrasound test of the lungs and heart to help doctors decide how much fluid to give adults with septic shock. The goal is to find the most accurate way to guide treatment, which could lead to better recovery.
This study tests whether using ultrasound (heart imaging and blood-vessel scanning) helps doctors treat septic shock—a life-threatening blood infection—more effectively. The trial measures whether these imaging tools help guide fluid and medication decisions during resuscitation.
This study uses a special ultrasound (Doppler) to check blood flow to your organs during septic shock. It helps doctors see if your body is getting enough blood and oxygen, which may guide better treatment.
This trial tests if using focused ultrasound to stimulate the spleen can reduce inflammation in septic shock. It may help patients in the ICU who need strong blood pressure support.
This study tests if a simple bedside heart ultrasound (echocardiogram) and blood tests can spot early heart problems in people with severe liver disease (cirrhosis) who are in the intensive care unit. It may help doctors better understand and manage heart complications in cirrhosis.
This study tests whether using a non-invasive monitor to guide fluid and medication decisions helps people with sepsis recover better than standard care. It aims to improve blood flow and organ function without extra needles or procedures.
Hear when a new Cirrhotic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.